Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): Pooled subset analyses from two randomized trials

  1. Ramalingam, S.S.
  2. O'Byrne, K.
  3. Boyer, M.
  4. Mok, T.
  5. Jänne, P.A.
  6. Zhang, H.
  7. Liang, J.
  8. Taylor, I.
  9. Sbar, E.I.
  10. Paz-Ares, L.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2016

Alea: 27

Zenbakia: 3

Orrialdeak: 423-429

Mota: Artikulua

DOI: 10.1093/ANNONC/MDV593 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus